The small scale bioreactors market is estimated to be valued at US$ 1508.86 Mn in 2023 and is expected to exhibit a CAGR of 10% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market Overview:
Small scale bioreactors are used for culturing mammalian and microbial cells in biopharmaceutical, drug discovery and tissue engineering applications. They are benchtop devices that can handle working volumes ranging from milliliters to few hundred liters. They are designed to closely replicate conditions within industrial large scale bioreactors. Continuous cell culture technology in small scale bioreactors is gaining popularity due to its ability to efficiently produce biomolecules while maintaining stable cell culture environment.

Market Dynamics:
The growth of the small scale bioreactors market is mainly driven by rising demand for continuous cell culture technology. Continuous cell culture allows uninterrupted culture of cells and maintains cell performance through multiple population doublings. It leverages perfusion culture methods that remove waste and replenishes nutrients at controlled rates keeping cells healthy and growing. This results in higher product yields as compared to batch culture method. Moreover, continuous manufacturing reduces production cycle time and increases operational flexibility.

A second driver for the market growth is increasing adoption of single-use bioreactors. Single-use bioreactors are pre-sterilized disposable bags for cell culture that eliminate the need for autoclaving, cleaning and validation of their glass and steel counterparts. This increases efficiency and flexibility of bioprocessing while reducing costs associated with cleaning and maintenance.

SWOT Analysis

Strength:
Growing pharmaceutical and biotechnology industries drive demand.
Ability to handle smaller batch sizes making them more cost effective for R&D activities.
Advancements in technologies help improve bioprocess optimization.

Weakness:

High initial investments and operating costs.
Require specialized training for operation and maintenance.

Opportunity:
Increasing R&D expenditures of pharmaceutical companies.
Growing focus on cell-based research activities.

Threats:
Availability of cheaper alternatives like shake flasks limits adoption.
Stringent regulatory policies slow approvals and market entry.


Key Takeaways

The global Small Scale Bioreactors Market Growth is expected to witness high growth, exhibiting a CAGR of 10% over the forecast period, due to increasing demand from pharma and biotech companies for R&D activities.

Regional analysis

North America dominated the market accounting for over 30% share in 2023 due to presence of major pharma companies investing in development of novel drug candidates in the region. Asia Pacific is expected to witness highest growth owing to expansion of biopharma industry and increasing outsourcing of clinical research to countries like China and India.

Key players

Key players operating in the small scale bioreactors market are Merck KGaA, Danaher Corporation, Getinge AB, Sartorius AG, Thermo Fisher Scientific Inc., Lonza Group, Eppendorf AG, Miltenyi Biotec, Solaris Biotechnology Srl, Infors AG, Biosan, MicroDigital Co. Ltd., 2mag AG, MDX Biotechnik International GmbH, Esco Lifesciences Group, HiTec Zang GmbH, Hanil Scientific Inc., Adolf Kühner AG, Ori Biotech, Aglaris and AdvaBio.

Read More,

https://cmiinfopiece.blogspot.com/2023/12/increasing-adoption-of-small-scale.html